Stock Research: iRhythm Technologies

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

iRhythm Technologies

NSQ:IRTC US4500561067
31
  • Value
    20
  • Growth
    51
  • Safety
    Safety
    10
  • Combined
    8
  • Sentiment
    100
  • 360° View
    360° View
    31
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

iRhythm Technologies, Inc. is a digital health care company creating solutions for disease detection, prediction, and prevention. The company operates in the healthcare industry, specializing in ambulatory cardiac monitoring services, including the Zio System options. The company offers services using its Zio Systems. In the last fiscal year, the company had a market cap of $4,312 million, profits of $408 million, and revenue of $592 million, with 2000 employees.

more

ANALYSIS: With an Obermatt 360° View of 31 (better than 31% compared with alternatives), overall professional sentiment and financial characteristics for the stock iRhythm Technologies are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for iRhythm Technologies. The consolidated Growth Rank has a good rank of 51, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 51% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 100, which means that professional investors are more optimistic about the stock than for 100% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 20, which means that the share price of iRhythm Technologies is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 80% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 10, which means that the company has a financing structure that is riskier than those of 90% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 21 21 15
Growth
51 77 55 33
Safety
Safety
10 44 9 6
Sentiment
100 57 81 25
360° View
360° View
31 61 27 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
68 87 93 74
Opinions Change
50 50 50 35
Pro Holdings
n/a 37 72 14
Market Pulse
93 43 42 18
Sentiment
100 57 81 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 21 21 15
Growth
51 77 55 33
Safety Safety
10 44 9 6
Combined
8 47 4 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
25 34 25 18
Price vs. Earnings (P/E)
100 15 15 2
Price vs. Book (P/B)
1 7 18 15
Dividend Yield
1 1 1 1
Value
20 21 21 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
61 75 73 77
Profit Growth
36 51 51 4
Capital Growth
43 81 43 81
Stock Returns
55 53 69 27
Growth
51 77 55 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
21 73 64 65
Refinancing
40 55 3 15
Liquidity
25 11 26 17
Safety Safety
10 44 9 6

Similar Stocks

Discover high‑ranked alternatives to iRhythm Technologies and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Humana

NYQ:HUM
Country: USA
Industry: Health Care Managed
Size: Large
Full Stock Analysis

Innoviva

NSQ:INVA
Country: USA
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: